Related Experiment Video
Updated: May 9, 2025

08:13
Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
Published on: April 5, 2024
716
Updates on adenomyosis and fertility
Maya Shats1, Michal Zajicek1, Matthew T Siedhoff2
1Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan.
Current Opinion in Obstetrics & Gynecology
|April 30, 2025
Summary
Fertility-sparing treatments for adenomyosis show promise but require more research. Careful patient selection is crucial to minimize risks like uterine rupture and improve pregnancy outcomes.
Area of Science:
- Reproductive Medicine
- Gynecologic Surgery
- Medical Imaging
Background:
- Adenomyosis, defined by endometrial tissue in the myometrium, causes pelvic pain, heavy bleeding, and infertility.
- Diagnosis primarily uses transvaginal ultrasound and MRI.
- Hysterectomy is curative, but fertility-sparing options are needed for younger patients.
Purpose of the Study:
- To review fertility-sparing interventions for adenomyosis.
- To evaluate their impact on fertility and obstetrical outcomes.
Main Methods:
- Review of current literature on adenomyosis management.
- Analysis of minimally invasive and surgical fertility-sparing techniques.
- Evaluation of reported fertility and obstetrical outcomes.
Main Results:
- Adenomyosis is linked to higher risks of pregnancy loss, preterm birth, and pre-eclampsia.
- Thermal ablation and hysteroscopic adenomyomectomy are potential fertility-sparing options.
- Laparoscopic and laparotomy surgeries are also explored, but comparative data is limited.
- Long-term fertility data and complication risks (e.g., uterine rupture) require further investigation.
Conclusions:
- Fertility-sparing interventions for adenomyosis have variable success rates.
- Larger trials with standardized criteria are needed to assess long-term outcomes and optimize patient selection.
- Potential risks include uterine rupture and placenta accreta spectrum, necessitating careful monitoring.
More Related Videos
Related Concept Videos
Oogenesis
63.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.1K
Infertility in Females
184
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
184
Disorders of the Female Reproductive System
204
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
204
Infertility in Males
153
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
153
Proliferative Phase
232
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
232
Ovarian Cycle
692
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
692

